BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND ERBB3, c-erbB3, 2065, P21860, p180-ErbB3, c-erbB-3, ErbB-3, MDA-BF-1, HER3, p85-sErbB3, MGC88033, p45-sErbB3, ENSG00000065361, erbB3-S AND Treatment
24 results:

  • 1. The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein.
    Lucas LM; Dwivedi V; Senfeld JI; Cullum RL; Mill CP; Piazza JT; Bryant IN; Cook LJ; Miller ST; Lott JH; Kelley CM; Knerr EL; Markham JA; Kaufmann DP; Jacobi MA; Shen J; Riese DJ
    Pharmacol Rev; 2022 Jan; 74(1):18-47. PubMed ID: 34987087
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Poor prognosis of male triple-positive breast cancer patients: a propensity score matched SEER analysis and molecular portraits.
    Wang B; Wang H; Zhao A; Zhang M; Yang J
    BMC Cancer; 2021 May; 21(1):523. PubMed ID: 33964913
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A Non-interventional Clinical Trial Assessing Immune Responses After Radiofrequency Ablation of Liver Metastases From Colorectal cancer.
    Löffler MW; Nussbaum B; Jäger G; Jurmeister PS; Budczies J; Pereira PL; Clasen S; Kowalewski DJ; Mühlenbruch L; Königsrainer I; Beckert S; Ladurner R; Wagner S; Bullinger F; Gross TH; Schroeder C; Sipos B; Königsrainer A; Stevanović S; Denkert C; Rammensee HG; Gouttefangeas C; Haen SP
    Front Immunol; 2019; 10():2526. PubMed ID: 31803175
    [No Abstract]    [Full Text] [Related]  

  • 4. Advanced development of ErbB family-targeted therapies in osteosarcoma treatment.
    Wang W; Zhao HF; Yao TF; Gong H
    Invest New Drugs; 2019 Feb; 37(1):175-183. PubMed ID: 30353245
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identification of therapeutic targets in chordoma through comprehensive genomic and transcriptomic analyses.
    Liang WS; Dardis C; Helland A; Sekar S; Adkins J; Cuyugan L; Enriquez D; Byron S; Little AS
    Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30322893
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Impact of number versus location of metastases on survival in stage IV M1b non-small cell lung cancer.
    Gibson AJW; Li H; D'Silva A; Tudor RA; Elegbede AA; Otsuka SM; Bebb DG; Cheung WY
    Med Oncol; 2018 Aug; 35(9):117. PubMed ID: 30073425
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Lapatinib.
    Voigtlaender M; Schneider-Merck T; Trepel M
    Recent Results Cancer Res; 2018; 211():19-44. PubMed ID: 30069757
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. RNA Profiles of Circulating Tumor Cells and Extracellular Vesicles for Therapy Stratification of Metastatic Breast cancer Patients.
    Keup C; Mach P; Aktas B; Tewes M; Kolberg HC; Hauch S; Sprenger-Haussels M; Kimmig R; Kasimir-Bauer S
    Clin Chem; 2018 Jul; 64(7):1054-1062. PubMed ID: 29769179
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Small-Molecule Activators of Protein Phosphatase 2A for the treatment of Castration-Resistant Prostate cancer.
    McClinch K; Avelar RA; Callejas D; Izadmehr S; Wiredja D; Perl A; Sangodkar J; Kastrinsky DB; Schlatzer D; Cooper M; Kiselar J; Stachnik A; Yao S; Hoon D; McQuaid D; Zaware N; Gong Y; Brautigan DL; Plymate SR; Sprenger CCT; Oh WK; Levine AC; Kirschenbaum A; Sfakianos JP; Sears R; DiFeo A; Ioannou Y; Ohlmeyer M; Narla G; Galsky MD
    Cancer Res; 2018 Apr; 78(8):2065-2080. PubMed ID: 29358171
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Evaluation of patritumab with or without erlotinib in combination with standard cytotoxic agents against pediatric sarcoma xenograft models.
    Bandyopadhyay A; Favours E; Phelps DA; Pozo VD; Ghilu S; Kurmashev D; Michalek J; Trevino A; Guttridge D; London C; Hirotani K; Zhang L; Kurmasheva RT; Houghton PJ
    Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 29080385
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS).
    Mora J; Castañeda A; Perez-Jaume S; Lopez-Pousa A; Maradiegue E; Valverde C; Martin-Broto J; Garcia Del Muro X; Cruz O; Cruz J; Martinez-Trufero J; Maurel J; Vaz MA; de Alava E; de Torres C
    Br J Cancer; 2017 Sep; 117(6):767-774. PubMed ID: 28787430
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [A randomized study of intensity-modulated radiation therapy versus three dimensional conformal radiation therapy for pelvic radiation in patients of post-operative treatment with gynecologic malignant tumor].
    Ni J; Yin ZM; Yuan SH; Liu NF; Li L; Xu XX; Lou HM
    Zhonghua Fu Chan Ke Za Zhi; 2017 Mar; 52(3):168-174. PubMed ID: 28355688
    [No Abstract]    [Full Text] [Related]  

  • 13. erbb3 silencing reduces osteosarcoma cell proliferation and tumor growth in vivo.
    Jullien N; Dieudonné FX; Habel N; Marty C; Modrowski D; Patino A; Lecanda F; Sévère N; Marie PJ
    Gene; 2013 May; 521(1):55-61. PubMed ID: 23541807
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The interplay of HER2/her3/PI3K and EGFR/HER2/PLC-γ1 signalling in breast cancer cell migration and dissemination.
    Balz LM; Bartkowiak K; Andreas A; Pantel K; Niggemann B; Zänker KS; Brandt BH; Dittmar T
    J Pathol; 2012 Jun; 227(2):234-44. PubMed ID: 22262199
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Human epidermal growth factor receptor bispecific ligand trap RB200: abrogation of collagen-induced arthritis in combination with tumour necrosis factor blockade.
    Gompels LL; Malik NM; Madden L; Jin P; Feldmann M; Shepard HM; Paleolog EM
    Arthritis Res Ther; 2011; 13(5):R161. PubMed ID: 21982514
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: randomised controlled trial.
    Adamsen L; Quist M; Andersen C; Møller T; Herrstedt J; Kronborg D; Baadsgaard MT; Vistisen K; Midtgaard J; Christiansen B; Stage M; Kronborg MT; Rørth M
    BMJ; 2009 Oct; 339():b3410. PubMed ID: 19826172
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Soluble erbb3 levels in bone marrow and plasma of men with prostate cancer.
    Lin SH; Lee YC; Choueiri MB; Wen S; Mathew P; Ye X; Do KA; Navone NM; Kim J; Tu SM; Yu-Lee LY; Logothetis CJ
    Clin Cancer Res; 2008 Jun; 14(12):3729-36. PubMed ID: 18559590
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The calcium sensing receptor: from understanding parathyroid calcium homeostasis to bone metastases.
    Mihai R
    Ann R Coll Surg Engl; 2008 May; 90(4):271-7. PubMed ID: 18492387
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The role of the EGFR signaling in tumor microenvironment.
    De Luca A; Carotenuto A; Rachiglio A; Gallo M; Maiello MR; Aldinucci D; Pinto A; Normanno N
    J Cell Physiol; 2008 Mar; 214(3):559-67. PubMed ID: 17894407
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Management of rash and other toxicities in patients treated with epidermal growth factor receptor-targeted agents.
    Rhee J; Oishi K; Garey J; Kim E
    Clin Colorectal Cancer; 2005 Nov; 5 Suppl 2():S101-6. PubMed ID: 16336749
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.